jueves, 3 de agosto de 2023
FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer
FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-trifluridine-and-tipiracil-bevacizumab-previously-treated-metastatic-colorectal-cancer
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario